Arrowstreet Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Arrowstreet Capital’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,934	Closed	-$425K	–	1539
2023 Q1	$425K	Buy	+11,934	New	+$433K	﹤0.01%	1202
2022 Q4	–	Sell	-6,729	Closed	-$317K	–	1520
2022 Q3	$317K	Buy	6,729 +2,564	+62%	+$166K	﹤0.01%	1157
2022 Q2	$299K	Sell	4,165 -57	-1%	-$4.17K	﹤0.01%	1123
2022 Q1	$342K	Buy	+4,222	New	+$357K	﹤0.01%	1065
2021 Q4	–	Sell	-6,500	Closed	-$569K	–	1814
2021 Q3	$569K	Sell	6,500 -38,200	-85%	-$3.46M	﹤0.01%	1396
2021 Q2	$4M	Buy	+44,700	New	+$3.78M	﹤0.01%	1136
2020 Q4	–	Sell	-447,314	Closed	-$23.8M	–	2601
2020 Q3	$23.8M	Sell	447,314 -137,463	-24%	-$8.19M	0.04%	482
2020 Q2	$34.1M	Buy	584,777 +461,432	+374%	+$24.8M	0.06%	303
2020 Q1	$4.86M	Buy	+123,345	New	+$7.21M	0.01%	753
2019 Q2	–	Sell	-366,777	Closed	-$19M	–	1789
2019 Q1	$19M	Buy	366,777 +351,777	+2,345%	+$17.1M	0.04%	380
2018 Q4	$590K	Buy	+15,000	New	+$697K	﹤0.01%	1065
2017 Q4	–	Sell	-16,800	Closed	-$879K	–	1425
2017 Q3	$879K	Buy	+16,800	New	+$937K	﹤0.01%	846
2016 Q2	–	Sell	-139,965	Closed	-$5.77M	–	1553
2016 Q1	$5.77M	Sell	139,965 -136,172	-49%	-$5.61M	0.02%	509
2015 Q4	$13.4M	Buy	276,137 +24,166	+10%	+$1.07M	0.06%	295
2015 Q3	$10.1M	Buy	251,971 +217,916	+640%	+$9.52M	0.05%	343
2015 Q2	$1.37M	Buy	+34,055	New	+$1.17M	0.01%	738

Other funds holding SYNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Arrowstreet Capital's SYNH Position: Q2 2023 in Review

Arrowstreet Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 11,934 shares — an estimated $425K sold.

Arrowstreet Capital first reported a position in SYNH in Q2 2015 and held it in 16 quarters. The position peaked at $34.1M in Q2 2020. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

Arrowstreet Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Arrowstreet Capital sold 11,934 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $425K.
Arrowstreet Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 16 quarters.
Arrowstreet Capital's Syneos Health, Inc. Class A Common Stock position peaked at $34.1M in Q2 2020.
317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Arrowstreet Capital's 13F filing for Q2 2023, filed 14 Aug 2023.